Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...

This project involved a collaborative meeting in Hanover, Germany in October 2017. The collaborators were the InterAcademy Partnership and the European Academies Science Advisory Concil. The workshop ...

Scientists who have described in a new study the step-by-step details of a bacterial defense strategy see the mechanism as a promising platform for development of a new genome-editing method.

Genome editing is no longer a futuristic concept — scientists are already rewriting the genetic material of living organisms ...

CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce ...

Both CBEs and ABEs have been extensively engineered to improve their efficiency, specificity, and targeting range, enabling a wide variety of base pair conversions across the genome. Base editing can ...